文献速递甲状腺与浅表US

评估99mTc-MIBI甲状腺显像用于诊断胺碘酮诱发甲状腺毒症

Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis.
PubMed 文献 · Br J Radiol · 2017-01-20

该研究对15例胺碘酮诱发甲状腺毒症(AIT)患者行99mTc-MIBI甲状腺显像进行分型,并与彩色多普勒超声、24小时放射性碘摄取率和99mTcO4显像等常规方法比较。结果显示I型AIT表现为甲状腺组织对MIBI高摄取和高滞留,II型AIT表现为低摄取,混合型介于两者之间;MIBI显像误诊率低于其他方法,能准确识别I型、II型和混合型AIT。

要点

  • I型AIT甲状腺组织对99mTc-MIBI呈高摄取和高滞留。
  • II型AIT甲状腺组织对99mTc-MIBI呈低摄取,与I型形成鲜明对比。
  • 混合型AIT的MIBI摄取值介于I型和II型之间。

核心结论

  • MIBI显像通过显示不同类型AIT的 distinct 图像,能准确识别I型、II型和混合型AIT,是诊断和分类AIT的可靠方法,其误诊率低于其他评估方法。

研究设计与样本

  • 对15例AIT患者行99mTc-MIBI甲状腺显像进行AIT分型,并与彩色多普勒超声、24小时放射性碘摄取率和99mTcO4显像等常规方法比较。

关键影像表现/征象

  • I型AIT甲状腺组织对MIBI呈高摄取和高滞留。
  • II型AIT甲状腺组织对MIBI呈低摄取。
  • 混合型AIT的MIBI摄取值介于I型和II型之间。

诊断标准与关键数值

  • I型AIT:甲状腺组织MIBI高摄取和高滞留。
  • II型AIT:甲状腺组织MIBI低摄取。
  • 混合型AIT:MIBI摄取值介于I型和II型之间。
  • MIBI显像误诊率低于彩色多普勒超声、24小时放射性碘摄取率和99mTcO4显像等其他方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Amiodarone-induced thyrotoxicosis (AIT) is caused by amiodarone as a side effect of cardiovascular disease treatment. Based on the differences in their pathological and physiological mechanisms, many methods have been developed so far to differentiate AIT subtypes such as colour flow Doppler sonography (CFDS) and 24-h radioiodine uptake (RAIU). However, these methods suffer from inadequate accuracy in distinguishing different types of AITs and sometimes lead to misdiagnosis and delayed treatments. Therefore, there is an unmet demand for an efficient method for accurate classification of AIT.

METHODS: Technetium-99 methoxyisobutylisonitrile (99mTc-MIBI) thyroid imaging was performed on 15 patients for AIT classification, and the results were compared with other conventional methods such as CFDS, RAIU and 99mTcO4 imaging.

RESULTS: High uptake and retention of MIBI in thyroid tissue is characteristic in Type I AIT, while in sharp contrast, low uptake of MIBI in the thyroid tissue was observed in Type II AIT. Mixed-type AIT shows uptake value between Types I and II. MIBI imaging outperforms other methods with a lower misdiagnosis rate.

CONCLUSION: Among the methods evaluated, MIBI imaging enables an accurate identification of Type I, II and mixed-type AITs by showing distinct images for different types of AITs. The results obtained from our selected subjects revealed that MIBI imaging is a reliable method for diagnosis and classification of AITs and MIBI imaging has potential in the treatment of thyroid diseases. Advances in knowledge: 99mTc-MIBI imaging is a useful method for the diagnosis of AIT. It can distinguish different types of AITs especially for mixed-type AIT, which is usually difficult to treat. 99mTc-MIBI has potential advantages over conventional methods in the efficient treatment of AIT.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang J, Zhang R. Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis. Br J Radiol. 2017. PMID: 28106465. doi:10.1259/bjr.20160836

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。